**Question:** True regarding Sjogren's syndrome are all of the following except: September 2009

A. **Increased risk of malignancies**
B. **Significantly reduced life expectancy**
C. **Rapidly progressive glomerulonephritis**
D. **Reduced risk of Parkinson's disease**

**Core Concept:** Sjögren's syndrome is a chronic autoimmune disorder primarily affecting exocrine glands, leading to dry eyes and dry mouth (xerophthalmia and xerostomia, respectively). The disease is characterized by lymphocyte infiltration and destruction of the salivary and lacrimal glands, leading to the production of reduced or absent secretions.

**Why the Correct Answer is Right:**

D. **Reduced risk of Parkinson's disease**: Sjögren's syndrome does not directly affect the substantia nigra, the brain region primarily affected in Parkinson's disease. While the disease itself does not increase the risk of Parkinson's, the medications used to treat Sjögren's syndrome, such as corticosteroids, have been associated with an increased risk for Parkinson's disease. However, this is a potential complication and does not apply to the general population of Sjögren's patients.

C. **Rapidly progressive glomerulonephritis**: Sjögren's syndrome does not directly lead to rapidly progressive glomerulonephritis. The primary focus of the disease is on exocrine glands, and renal involvement in Sjögren's occurs in only about 5-10% of cases.

A. **Increased risk of malignancies**: Sjögren's syndrome is associated with an increased risk of certain malignancies, particularly lymphoproliferative disorders like non-Hodgkin lymphoma and Hodgkin lymphoma, as well as, to a lesser extent, solid tumors such as breast, lung, and thyroid cancers.

B. **Significantly reduced life expectancy**: Sjögren's syndrome does not inherently result in a reduced life expectancy. The prognosis for Sjögren's patients is generally good when managed appropriately with immunosuppressive medications and supportive care. However, the increased risk of malignancies mentioned above can influence overall life expectancy if left untreated or inadequately managed.

**Why Each Wrong Answer is Incorrect:**

C. Rapidly progressive glomerulonephritis: As mentioned, renal involvement in Sjögren's syndrome is quite rare, making this statement incorrect.

D. Reduced life expectancy: While Sjögren's syndrome itself does not directly reduce life expectancy, the increased risk of malignancies associated with the disease can impact overall life expectancy. However, the actual life expectancy of a patient with Sjögren's syndrome is not reduced due to the disease itself.

**Clinical Pearls:**

1. **Monitoring for malignancies**: Given the increased risk of lymphoproliferative disorders and solid tumors in Sj